Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Upregulation of NADH/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis: Tae-Sun Ha, Su-Bin Seong, Dong-Soo Ha, Seung Jung Kim; Kidney Res Clin Pract. 2023;42(2):202-215. Published online March 31, 2023; DOI: https://doi.org/10.23876/j.krcp.22.198
Cited By 1; Full text PubReader ePub PDF

Review Articles

The role of renal proximal tubule transport in the regulation of blood pressure: Shoko Horita, Motonobu Nakamura, Masashi Suzuki et al.; Kidney Res Clin Pract. 2017;36(1):12-21. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.12
Web of Science 16 Cited By 19; Full text PubReader PDF

Original Articles

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients: Eun Seok Kim, Hyun Jeong Kim, Yong Jun Kim et al.; Kidney Res Clin Pract. 2013;32(4):158-163. Published online November 2, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.09.002
Cited By 7; Full text PubReader PDF

Retrospective Comparisons about Effects of Angiotensin II Receptor Blocker and/or Steroid on Proteinuria Reduction and Renal Protection in IgA Nephropathy Patients with Proteinuria less than 1 g/g: Seung-Joon Hwang, M.D., So Young Choi, M.D., Sung Yeon Cho, M.D., Ji Young Park, M.D., Kyung-Hwan Jung, M.D., Joo-Yung Moon, M.D., Sang Ho Lee, M.D., Tae Won Lee, M.D. and Chun Gyoo Ihm, M.D.; Korean J Nephrol. 2009;28(6):579-587.; PDF

Renovascular Hypertension and Nephrotic Range Proteinuria Developed after the Renal Artery Ligation: Successful Treatment by Combination of ACE Inhibitor and Angiotensin II Type 1 Receptor Blocker: Se-Won Oh, M.D., Sun-Chul Kim, M.D., Jin-Joo Cha, M.D., Myung-gyu Kim, M.D., Young-Seok Woo, M.D., Chang-Su Boo, M.D., Sang-Kyung Jo, M.D., Won-Yong Cho, M.D. and Hyoung-Kyu Kim, M.D.; Korean J Nephrol. 2009;28(3):230-235.; PDF

Add-on Therapy of Potassium-exchange Resin for Hyperkalemia in Chronic Kidney Disease Patients on Renin-angiotensin System Blockers: Joo-Hark Yi, M.D., Yeo-Wook Yun, M.D., Useok Noh, M.D., Eun-Young Kim, M.D. Jae-Il Park, M.D., Sang-Woong Han, M.D. and Ho-Jung Kim, M.D.; Korean J Nephrol. 2007;26(5):534-540.; PDF

Effects of Angiotensin II on ZO-1 in Glomerular Epithelial Cells: Hyun-Hoe Koo, M.D. and Tae-Sun Ha, M.D.; Korean J Nephrol. 2007;26(5):516-525.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,566	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,512	C4d Puzzle in ABO-incompatible kidney transplantation
7,918	How should we treat acute kidney injury caused by renal congestion?
12,725	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,812	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.